Martin O'Malley

Martin O'Malley's policies onHealthcare

Use the government’s purchasing power to ensure reasonable drug prices

Today, drug companies have too much market power when they hold the patent for a new drug—and sometimes even when they don’t. We should be proud that America leads the world in developing life-saving cures, but the world’s drug innovation should not be subsidized on the backs of the sickest patients in the United States. And companies should be able to make a reasonable rate of return on their investments in critical research and design, but not price their products to extract every possible dollar from the rest of the economy. O’Malley will urge Congress to allow Medicare to negotiate for better drug prices, together with Medicaid and the VA.

Found an error or want to make a contribution?